Grupo Aval Acciones Y Valores S.A. current report, Q4 FY2016

Business Context and Reporting Period

This Form 6-K filing by Grupo Aval Acciones y Valores S.A. covers the month of December 2016, with the report dated December 19, 2016. The filing serves as a notice of relevant information regarding a strategic divestiture by a subsidiary of the registrant.

Key Financial Metrics

The filing does not provide consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics for Grupo Aval. It specifically references the following data points related to the transaction:

  • Credomatic de Mexico Portfolio: Approximately US$49.2 million (net of allowances).
  • BAC Credomatic Group Total Portfolio: More than US$14 billion.
  • Portfolio Share: The Mexican portfolio represents 0.4% of the total BAC Credomatic Group portfolio.

Material Changes

On December 16, 2016, Credomatic de Mexico S.A. de C.V., a subsidiary of BAC International Bank Inc. (which is part of Grupo Aval), entered into an agreement to sell its credit card portfolio in Mexico to Banco Invex S.A. This transaction is a material change in the company's geographic footprint and asset composition.

Guidance, Outlook, and Management Commentary

Strategic Rationale: The sale aligns with BAC International Bank Inc.'s strategy to concentrate its banking and credit card operations in Panama, Costa Rica, El Salvador, Nicaragua, Honduras, and Guatemala.

Transaction Timeline: Subject to regulatory approvals, the transaction is expected to close during the first semester of 2017.

Entity Profile: Credomatic de Mexico, which began operations in 2004, operates as a credit card issuer without a banking license.

Investor Verification Checklist

  • Confirm the final closing date of the transaction, as it is contingent on regulatory approvals.
  • Verify the final sale price and any potential gain or loss on the disposal of the US$49.2 million portfolio.
  • Assess the impact of the divestiture on future revenue streams from the Mexican market.
  • Review subsequent filings for updates on the regulatory approval status in Mexico.